Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-001470
Filing Date
2023-06-09
Accepted
2023-06-09 20:10:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3222
  Complete submission text file 0001950047-23-001470.txt   4550
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Subject) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36740 | Film No.: 231006850
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Cravatt Benjamin (Reporting) CIK: 0001819573 (see all company filings)

Type: 144